↓ Skip to main content
What is this page? Embed badge

Resistance to Immunotoxins in Cancer Therapy

Overview of attention for book
Cover of 'Resistance to Immunotoxins in Cancer Therapy'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Targeted Cancer Therapy: History and Development of Immunotoxins
  3. Altmetric Badge
    Chapter 2 Immunotoxins, Resistance and Cancer Stem Cells: Future Perspective
  4. Altmetric Badge
    Chapter 3 Factors that Determine Sensitivity and Resistances of Tumor Cells Towards Antibody-Targeted Protein Toxins
  5. Altmetric Badge
    Chapter 4 Cell Signaling and Resistance to Immunotoxins
  6. Altmetric Badge
    Chapter 5 Antibody-Drug Conjugates and Immunotoxins for the Treatment of Hematologic Neoplasms
  7. Altmetric Badge
    Chapter 6 Challenges for Therapeutic Application of Pseudomonas Exotoxin-Based Immunotoxins
  8. Altmetric Badge
    Chapter 7 Drug Resistance to Calicheamicin Conjugated Monoclonal Antibody Therapy
  9. Altmetric Badge
    Chapter 8 Engineered Versions of Granzyme B and Angiogenin Overcome Intrinsic Resistance to Apoptosis Mediated by Human Cytolytic Fusion Proteins
  10. Altmetric Badge
    Chapter 9 Therapeutic Impact of Immune Responses in Cancer
Attention for Chapter 5: Antibody-Drug Conjugates and Immunotoxins for the Treatment of Hematologic Neoplasms
Altmetric Badge

Citations

dimensions_citation
3 Dimensions
Summary Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Antibody-Drug Conjugates and Immunotoxins for the Treatment of Hematologic Neoplasms
Chapter number 5
Book title
Resistance to Immunotoxins in Cancer Therapy
Published by
Springer, Cham, January 2015
DOI 10.1007/978-3-319-17275-0_5
Book ISBNs
978-3-31-917274-3, 978-3-31-917275-0
Authors

Tadeusz Robak, Pawel Robak

View on publisher site

This page is provided by Altmetric.